Latest News
These are CLL Ireland’s latest news posts from Facebook – but make sure to visit our CLL Ireland Facebook page for older posts.
Our friends in Lymphoma Coalition are running this survey and would appreciate our help in collecting information about living with lymphoma including CLL/SLL.
This is important work, please complete, like and share!
www.lymphomacoalition.org
The Lymphoma Coalition is a global network of worldwide not for profit lymphoma patient organizations with a Vision to free the world of lymphomas.Nicole Lamanna, MD, is an Associate Clinical Professor of Medicine in the Hematologic Malignancies Section of the Hematology/Oncology Division. Dr. Lamanna is a hematologist/oncologist whose research interests include lymphoid leukemias, specifically chronic lymphocytic leukemia.
She is an experienced clinical investigator and her research focus has been the development of combination therapies that include chemoimmunotherapy, immunomodulatory drugs, novel kinase inhibitors and monoclonal antibodies. She also is working to find active, safer therapies for older patients with these diseases.
Exciting times for CLL patients and research, we are getting closer, but mature data is required to evidence long term benifits and tests that will be key to stratify patients and tailor their treatment plans
youtu.be/0ojUKhfvXL4
CLL Update 2 - Prof Nicole Lamanna - ASH 2019 - Testing & Tailoring Treatment
youtu.be
Dr. Nicole Lamanna, Associate Clinical Professor of haematological malignancies at Columbia University Medical Centre discusses the different CLL sub groups,...Prof Florence Cymbalista of Avicenne Hospital, Paris, France at ASH 2019 discusses the evolving CLL treatment landscape, ASH hot topics: next generation BTK inhibitors, MRDu, combination therapies and treatment sequencing
youtu.be/13fvUiMjJQM
CLL Update 1 - Prof Florence Cymbalista - ASH 2019 - The evolving treatment landscape
youtu.be
Prof Cymbalista of Avicenne Hospital, Paris, France discusses the changing treatment landscape in CLL and ASH hot topics: next generation BTK inhibitors, MRD...Wishing all those in our #CLL community, and all those who help us do what we do, a 2020 that is filled with love and improved health options for all. We've a feeling that great things are just around the corner...
This is an interesting article in today’s daily mail about the UK CLL trials and their success. The Clarity trial mentioned in this article in leeds is led by Prof Peter Hillmen who was one of our keynote speakers at our Dublin info day 2018 ( if you missed it you can catch the recording on our website)
www.dailymail.co.uk/health/article-7832767/amp/Revolutionary-two-pronged-attack-thats-beating-inc...
Revolutionary two-pronged attack beating 'incurable' blood cancer
www.dailymail.co.uk
Professor Lelia Duley, 61, from Southwell in Nottinghamshire, is one of the patients involved in a drug combination trial to combat chronic lymphocytic leukaemia.MD Anderson shares a simple video to help us understand CAR T therapy which is a promising new treatment in CLL and also shows potential in other cancers.
To all of our CLL community at home and away heartfelt festive greetings to you and families. We are looking forward to a busy and exciting 2020.
Good news from this years ASH.
These newer treatments are still not available widely but data suggests that there are good future options for CLL patients coming down the line.
www.cancertherapyadvisor.com
There is an increasing focus on using the achievement of undetectable MRD in bone marrow as a clinical trial end point in patients with CLL.Did you know that we have published the presentations from last month's event in Galway on our You Tube channel? Why not watch Dr Amjad Hayat's brilliant talk about #CLL prognostic factors, treatment evolution and modern managment. Dr Louise Concannon, Clinical Psychologist also discusses coping styles, our response to stress, the impact of thoughts & actions on emotional well-being and practical tools to help. Sheila Biggins shares her remarkable journey from diagnosis through to her partaking on a Clinical Trial here in Ireland
